These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33325713)

  • 21. The impact of azole antifungal drugs on imatinib metabolism in human liver microsomes.
    Luo X; Li T; Yu Z; Xue X; Zhao H; Li N; Ma L; Yang C; Huang L; Feng W
    Xenobiotica; 2019 Jul; 49(7):753-761. PubMed ID: 29770723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solubility parameter-based screening methods for early-stage formulation development of itraconazole amorphous solid dispersions.
    Piccinni P; Tian Y; McNaughton A; Fraser J; Brown S; Jones DS; Li S; Andrews GP
    J Pharm Pharmacol; 2016 May; 68(5):705-20. PubMed ID: 26864155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-azole-resistant strain of Malassezia pachydermatis isolated from a canine Malassezia dermatitis.
    Kano R; Yokoi S; Kariya N; Oshimo K; Kamata H
    Med Mycol; 2019 Apr; 57(3):346-350. PubMed ID: 29800467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How does pressure affect the molecular dynamics, intramolecular interactions, and the relationship between structural (α) and secondary (JG-β) relaxation above and below the glass transition temperature in binary mixtures of H-bonded API - probucol and acetylated saccharides?
    Minecka A; Hachuła B; Kamiński K; Paluch M; Kamińska E
    Eur J Pharm Sci; 2021 Sep; 164():105894. PubMed ID: 34089820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New antifungal agents in the treatment of superficial dermatomycoses].
    Degreef H
    Ann Dermatol Venereol; 1993; 120(1):21-31. PubMed ID: 8393313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular dynamics of itraconazole at ambient and high pressure.
    Tarnacka M; Adrjanowicz K; Kaminska E; Kaminski K; Grzybowska K; Kolodziejczyk K; Wlodarczyk P; Hawelek L; Garbacz G; Kocot A; Paluch M
    Phys Chem Chem Phys; 2013 Dec; 15(47):20742-52. PubMed ID: 24196752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous determination of seven azole antifungal drugs in serum by ultra-high pressure liquid chromatography and diode array detection.
    Mistretta V; Dubois N; Denooz R; Charlier C
    Acta Clin Belg; 2014; 69(1):53-61. PubMed ID: 24635400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
    Jesus FP; Lautert C; Zanette RA; Mahl DL; Azevedo MI; Machado ML; Dutra V; Botton SA; Alves SH; Santurio JM
    Vet Microbiol; 2011 Aug; 152(1-2):161-4. PubMed ID: 21658868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods.
    Cafarchia C; Figueredo LA; Iatta R; Colao V; Montagna MT; Otranto D
    Med Mycol; 2012 Nov; 50(8):795-801. PubMed ID: 22471886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
    Odds FC; Webster CE; Abbott AB
    J Antimicrob Chemother; 1984 Aug; 14(2):105-14. PubMed ID: 6094418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro antifungal activity of itraconazole: a comparative study with ketoconazole].
    Hiratani T; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):580-7. PubMed ID: 1652656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral azole drugs as systemic antifungal therapy.
    Como JA; Dismukes WE
    N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcription factor ADS-4 regulates adaptive responses and resistance to antifungal azole stress.
    Wang K; Zhang Z; Chen X; Sun X; Jin C; Liu H; Li S
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5396-404. PubMed ID: 26100701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.
    Venkateswarlu K; Denning DW; Kelly SL
    J Med Vet Mycol; 1997; 35(1):19-25. PubMed ID: 9061581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azole antifungal agents.
    Bodey GP
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S161-9. PubMed ID: 1314105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dermatophyte susceptibilities to antifungal azole agents tested in vitro by broth macro and microdilution methods.
    Siqueira ER; Ferreira JC; Pedroso RS; Lavrador MA; Candido RC
    Rev Inst Med Trop Sao Paulo; 2008; 50(1):1-5. PubMed ID: 18327478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic optimisation of oral antifungal therapy.
    Schäfer-Korting M
    Clin Pharmacokinet; 1993 Oct; 25(4):329-41. PubMed ID: 8261715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of the antifungal azoles itraconazole, fluconazole, ketoconazole and miconazole on cytokine gene expression in human lymphoid cells.
    Friccius H; Pohla H; Adibzadeh M; Siegels-Hübenthal P; Schenk A; Pawelec G
    Int J Immunopharmacol; 1992 Jul; 14(5):791-9. PubMed ID: 1380951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal Activity of
    Roana J; Mandras N; Scalas D; Campagna P; Tullio V
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33477259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.